SCHEDULE: Jorey Chernett Discloses 6.13% Stake in Tiziana Life Sciences

Jorey Chernett has reported beneficial ownership of 6.13% of Tiziana Life Sciences Ltd's common stock, holding 7,326,471 shares.

Summary

• Jorey Chernett, a U.S. citizen, has filed an Amendment No. 1 to Schedule 13G regarding Tiziana Life Sciences Ltd.
• Chernett beneficially owns 7,326,471 shares of Tiziana Life Sciences Ltd's common stock.
• This ownership represents 6.13% of the total class of securities.
• Chernett holds sole voting power and sole dispositive power over all 7,326,471 shares.
• The filing certifies that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: This is a factual disclosure of beneficial ownership, which is neutral in sentiment. It simply reports a significant stake without indicating positive or negative performance or outlook.

Future Outlook

NA

Management Comments

• I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders: Disclosure of a significant beneficial owner provides transparency regarding the company's ownership structure, which can influence investor perception and potentially signal confidence or interest from large investors.

Key Dates

Keywords

Tiziana Life Sciences, Jorey Chernett, Beneficial Ownership, Schedule 13G, Common Stock, Shareholder, SEC Filing